Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed No phase listed Observational

A Clinical Assessment Study in X-Linked Myotubular Myopathy (XLMTM) Subjects

ClinicalTrials.gov ID: NCT02704273

Public ClinicalTrials.gov record NCT02704273. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 28, 2026, 12:23 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

INCEPTUS: A Prospective, Non-Interventional Clinical Assessment Study in X Linked Myotubular Myopathy (XLMTM) Subjects Aged 3 Years and Younger

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

This is a pre-Phase 1 prospective, non interventional clinical assessment study to evaluate XLMTM subjects aged 3 years and younger. Many of these clinically relevant measures have not yet been routinely assessed in this population and may provide important insight on the natural history of XLMTM and for future evaluation of potential therapies.

Study identification

NCT ID
NCT02704273
Recruitment status
Completed
Study type
Observational
Phase
Not listed
Lead sponsor
Astellas Gene Therapies
Industry
Enrollment
34 participants

Conditions and interventions

Interventions

Not listed

Eligibility (public fields only)

Age range
Up to 3 Years
Sex
Male
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jul 2016 (Type not available)
Primary completion
Sep 2019 (Actual)
Completion
Sep 2019 (Actual)
Last update posted
Jul 29, 2022

2016 – 2019

United States locations

U.S. sites
4
U.S. states
4
U.S. cities
4
Facility City State ZIP Site status
UCLA Los Angeles California 90095 —
University of Florida Gainesville Florida 32610 —
Ann & Robert H. Lurie Children's Hospital of Chicago Chicago Illinois 60611 —
National Institute of Neurological Disorders and Stroke/NIH Porter Bethesda Maryland 20892 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 4 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT02704273, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jul 29, 2022 · Synced Oct 28, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT02704273 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →